Insmed Overview
Insmed Target Price
Analysts' 12-month price predictions for INSM.
Share Price
$145.1
Average Target Price
$140.00
3.5% downside
3.5% downside1 analysts in the last 4 months
High: $140 | Low: $140
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-08-12 | Wells FargoTiago Fauth | $140 | 3.5% downside |  |
| 2025-03-06 | UBS | $110 | 24.2% downside | |
| 2024-08-15 | Mizuho SecuritiesGraig Suvannavejh | $92 | 36.6% downside | |
| 2024-08-09 | Wells FargoTiago Fauth | $85 | 41.4% downside | |
| 2024-07-09 | GuggenheimVamil Divan | $95 | 34.5% downside | |
| 2024-07-01 | Truist FinancialNicole Germino | $88 | 39.4% downside | |
| 2024-06-25 | BarclaysLeon Wang | $90 | 38% downside | |
| 2024-06-21 | Evercore ISILiisa Bayko | $75 | 48.3% downside | |
| 2024-06-07 | Mizuho SecuritiesGraig Suvannavejh | $82 | 43.5% downside | |
| 2024-06-05 | Stifel NicolausStephen Willey | $74 | 49% downside | |
| 2024-05-29 | Wells FargoTiago Fauth | $77 | 46.9% downside | |
| 2024-05-29 | H.C. WainwrightAndrew Fein | $70 | 51.8% downside | |
| 2024-05-29 | UBSTrung Huynh | $58 | 60% downside | |
| 2024-05-29 | Truist FinancialNicole Germino | $68 | 53.1% downside | |
| 2024-05-29 | Wolfe ResearchAndy Chen | $54 | 62.8% downside | |
| 2024-05-28 | Morgan StanleyJeffrey Hung | $60 | 58.6% downside | |
| 2024-05-28 | Goldman SachsAndrea Tan | $74 | 49% downside | |
| 2024-05-28 | Evercore ISILiisa Bayko | $42 | 71.1% downside | |
| 2024-05-13 | Mizuho SecuritiesGraig Suvannavejh | $36 | 75.2% downside | |
| 2024-05-09 | Morgan StanleyJeffrey Hung | $43 | 70.4% downside | |
| 2024-04-23 | Truist FinancialNicole Germino | $48 | 66.9% downside | |
| 2024-04-01 | Wells FargoTiago Fauth | $55 | 62.1% downside | |
| 2022-04-27 | Goldman Sachs | $56 | 61.4% downside | |